Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Drug devices facilitate early diagnosis and reduced treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.
The global drug device combination product market size is expected to reach USD 176 billion by 2024. Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.
The report details the trend, potential and market size of Drug Device Combination Products market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drug Device Combination Productsmarket, defines the market attractiveness level of Drug Device Combination Products market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drug Device Combination Products industry, describes the types of Drug Device Combination Products market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drug Device Combination Products market and the development prospects and opportunities of Drug Device Combination Products industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drug Device Combination Products market in Chapter 13.
By Player:
CR Bard, Inc
Mylan NV
Abbott Laboratories
Allergan, Plc
Boston Scientific Corporation
Medtronic
StJude Medical, Inc
Stryker Corporation
Teleflex Incorporated
Novartis AG
WLCore & Associates, Inc
Terumo Corporation
By Type:
Drug-eluting stents
Prefilled syringes
Wearable injectors
Insulin injector drug
By End-User:
Hospitals and Clinics
Medical Laboratories
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drug Device Combination Products Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drug Device Combination Products Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drug Device Combination Products Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drug Device Combination Products Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drug Device Combination Products Market Analysis and Outlook to 2022
-
7.1 Global Drug Device Combination Products Consumption (2017-2022)
-
7.2 United States Drug Device Combination Products Consumption (2017-2022)
-
7.3 Europe Drug Device Combination Products Consumption (2017-2022)
-
7.4 China Drug Device Combination Products Consumption (2017-2022)
-
7.5 Japan Drug Device Combination Products Consumption (2017-2022)
-
7.6 India Drug Device Combination Products Consumption (2017-2022)
-
7.7 South Korea Drug Device Combination Products Consumption (2017-2022)
8 Region and Country-wise Drug Device Combination Products Market Analysis and Outlook to 2028
-
8.1 Global Drug Device Combination Products Consumption Forecast (2022-2028)
-
8.2 United States Drug Device Combination Products Consumption Forecast (2022-2028)
-
8.3 Europe Drug Device Combination Products Consumption Forecast (2022-2028)
-
8.4 China Drug Device Combination Products Consumption Forecast (2022-2028)
-
8.5 Japan Drug Device Combination Products Consumption Forecast (2022-2028)
-
8.6 India Drug Device Combination Products Consumption Forecast (2022-2028)
-
8.7 South Korea Drug Device Combination Products Consumption Forecast (2022-2028)
9 Global Drug Device Combination Products Market Outlook by Types and Applications to 2022
-
9.1 Global Drug Device Combination Products Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Drug-eluting stents Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prefilled syringes Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Wearable injectors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Insulin injector drug Consumption and Growth Rate (2017-2022)
-
9.2 Global Drug Device Combination Products Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Drug Device Combination Products Market Outlook by Types and Applications to 2028
-
10.1 Global Drug Device Combination Products Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Drug-eluting stents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prefilled syringes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Wearable injectors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Insulin injector drug Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drug Device Combination Products Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Drug Device Combination Products Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drug Device Combination Products Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drug Device Combination Products Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drug Device Combination Products Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drug Device Combination Products Market Competitive Analysis
-
14.1 CR Bard, Inc
-
14.1.1 CR Bard, Inc Company Details
-
14.1.2 CR Bard, Inc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CR Bard, Inc Drug Device Combination Products Product and Service
-
14.2 Mylan NV
-
14.2.1 Mylan NV Company Details
-
14.2.2 Mylan NV Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mylan NV Drug Device Combination Products Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Drug Device Combination Products Product and Service
-
14.4 Allergan, Plc
-
14.4.1 Allergan, Plc Company Details
-
14.4.2 Allergan, Plc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Allergan, Plc Drug Device Combination Products Product and Service
-
14.5 Boston Scientific Corporation
-
14.5.1 Boston Scientific Corporation Company Details
-
14.5.2 Boston Scientific Corporation Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boston Scientific Corporation Drug Device Combination Products Product and Service
-
14.6 Medtronic
-
14.6.1 Medtronic Company Details
-
14.6.2 Medtronic Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Medtronic Drug Device Combination Products Product and Service
-
14.7 StJude Medical, Inc
-
14.7.1 StJude Medical, Inc Company Details
-
14.7.2 StJude Medical, Inc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 StJude Medical, Inc Drug Device Combination Products Product and Service
-
14.8 Stryker Corporation
-
14.8.1 Stryker Corporation Company Details
-
14.8.2 Stryker Corporation Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Stryker Corporation Drug Device Combination Products Product and Service
-
14.9 Teleflex Incorporated
-
14.9.1 Teleflex Incorporated Company Details
-
14.9.2 Teleflex Incorporated Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teleflex Incorporated Drug Device Combination Products Product and Service
-
14.10 Novartis AG
-
14.10.1 Novartis AG Company Details
-
14.10.2 Novartis AG Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis AG Drug Device Combination Products Product and Service
-
14.11 WLCore & Associates, Inc
-
14.11.1 WLCore & Associates, Inc Company Details
-
14.11.2 WLCore & Associates, Inc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 WLCore & Associates, Inc Drug Device Combination Products Product and Service
-
14.12 Terumo Corporation
-
14.12.1 Terumo Corporation Company Details
-
14.12.2 Terumo Corporation Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Terumo Corporation Drug Device Combination Products Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drug Device Combination Products
-
Figure Drug Device Combination Products Picture
-
Table Global Drug Device Combination Products Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drug Device Combination Products Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drug Device Combination Products Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drug Device Combination Products Consumption by Country (2017-2022)
-
Figure United States Drug Device Combination Products Consumption and Growth Rate (2017-2022)
-
Table Europe Drug Device Combination Products Consumption and Growth Rate (2017-2022)
-
Figure China Drug Device Combination Products Consumption and Growth Rate (2017-2022)
-
Figure Japan Drug Device Combination Products Consumption and Growth Rate (2017-2022)
-
Figure India Drug Device Combination Products Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drug Device Combination Products Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Device Combination Products Consumption Forecast by Country (2022-2028)
-
Figure United States Drug Device Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drug Device Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drug Device Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drug Device Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drug Device Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drug Device Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug-eluting stents Consumption and Growth Rate (2017-2022)
-
Figure Global Prefilled syringes Consumption and Growth Rate (2017-2022)
-
Figure Global Wearable injectors Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin injector drug Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Drug-eluting stents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prefilled syringes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wearable injectors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin injector drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drug Device Combination Products Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drug Device Combination Products Export by Region (Top 5 Countries) (2017-2028)
-
Table CR Bard, Inc (Foundation Year, Company Profile and etc.)
-
Table CR Bard, Inc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table CR Bard, Inc Drug Device Combination Products Product and Service
-
Table Mylan NV (Foundation Year, Company Profile and etc.)
-
Table Mylan NV Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Drug Device Combination Products Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Drug Device Combination Products Product and Service
-
Table Allergan, Plc (Foundation Year, Company Profile and etc.)
-
Table Allergan, Plc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan, Plc Drug Device Combination Products Product and Service
-
Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)
-
Table Boston Scientific Corporation Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Drug Device Combination Products Product and Service
-
Table Medtronic (Foundation Year, Company Profile and etc.)
-
Table Medtronic Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Drug Device Combination Products Product and Service
-
Table StJude Medical, Inc (Foundation Year, Company Profile and etc.)
-
Table StJude Medical, Inc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table StJude Medical, Inc Drug Device Combination Products Product and Service
-
Table Stryker Corporation (Foundation Year, Company Profile and etc.)
-
Table Stryker Corporation Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stryker Corporation Drug Device Combination Products Product and Service
-
Table Teleflex Incorporated (Foundation Year, Company Profile and etc.)
-
Table Teleflex Incorporated Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teleflex Incorporated Drug Device Combination Products Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Drug Device Combination Products Product and Service
-
Table WLCore & Associates, Inc (Foundation Year, Company Profile and etc.)
-
Table WLCore & Associates, Inc Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table WLCore & Associates, Inc Drug Device Combination Products Product and Service
-
Table Terumo Corporation (Foundation Year, Company Profile and etc.)
-
Table Terumo Corporation Drug Device Combination Products Sales, Price, Value and Gross Profit (2017-2022)
-
Table Terumo Corporation Drug Device Combination Products Product and Service
-
